230 results on '"Enke, Charles A."'
Search Results
2. Predictive Value of Multiparametric Magnetic Resonance Imaging in Risk Group Stratification of Prostate Adenocarcinoma
3. p53/FBXL20 axis negatively regulates the protein stability of PR55α, a regulatory subunit of PP2A Ser/Thr phosphatase
4. PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation
5. Impact of statin use on overall and time to biochemical failure following radical prostatectomy or radiation therapy
6. Comparison of sequential versus concurrent chemoradiation regimens in non-metastatic muscle-invasive bladder cancer
7. Prostate intrafraction translation margins for real-time monitoring and correction strategies.
8. Comparison of transabdominal ultrasound and electromagnetic transponders for prostate localization
9. Automatic planning on hippocampal avoidance whole-brain radiotherapy
10. PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells
11. Recurrent Mantle Cell Lymphoma Isolated to the Testis After 19-Year Remission: A Case Report and Review of the Literature
12. Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions of the clinical target volume?
13. Survival Outcomes After Radiotherapy for the Treatment of Synchronous Oligometastatic Prostate Cancer
14. A Nonhuman Primate Model of Human Radiation-Induced Venocclusive Liver Disease and Hepatocyte Injury
15. Rac1 is a novel therapeutic target in mantle cell lymphoma
16. Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma
17. Using weighted power mean for equivalent square estimation
18. Effect of Radiotherapy Techniques (IMRT vs. 3D-CRT) on Outcome in Patients With Intermediate-Risk Rhabdomyosarcoma Enrolled in COG D9803—A Report From the Children’s Oncology Group
19. MP48-20 PROTECTIVE EFFECTS OF METFORMIN AGAINST BIOCHEMICAL FAILURE FOLLOWING RADICAL PROSTATECTOMY OR RADIATION THERAPY IN LOCALIZED PROSTATE CANCER
20. Protective Effects of Metformin Against Biochemical Failure Following Radical Prostatectomy or Radiation Therapy in Localized Prostate Cancer
21. Preclinical Evaluation of Investigational Radiopharmaceutical RISAD-P Intended for Use as a Diagnostic and Molecular Radiotherapy Agent for Prostate Cancer
22. Abstract 1986: p53/FBXL20 axis negatively regulates the protein stability of PR55α, a PP2A regulatory subunit
23. Comparison of Kodak EDR2 and Gafchromic EBT film for intensity-modulated radiation therapy dose distribution verification
24. Ultrasound-based guidance of intensity-modulated radiation therapy
25. Tolerable limits to whole liver irradiation in non-human primates: 1674
26. Abstract A44: PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells
27. Minimum dose rate estimation for pulsed FLASH radiotherapy: A dimensional analysis
28. Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
29. The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component
30. Prostate motion and isocenter adjustment from ultrasound-based localization during delivery of radiation therapy
31. VACCINATION OF PROSTATE CANCER PATIENTS WITH GENETICALLY MODIFIED ALLOGENEIC TUMOR CELL VACCINE INDUCES IgG RESPONSES TOWARD MULTIPLE PEPTIDE EPITOPES PREDICTED FROM COMMON PROSTATE TUMOR- ASSOCIATED AUTOANTIGENS: 654
32. Phase I Trial of Iodine-131 Tositumomab With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Relapsed Non-Hodgkinʼs Lymphoma
33. Dose linearity and uniformity of a linear accelerator designed for implementation of multileaf collimation system-based intensity modulated radiation therapy
34. Hodgkin’s Disease in the Elderly: Improved Treatment Outcome With a Doxorubicin-Containing Regimen
35. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
36. Times Not to Forget Radiotherapy When Treating Patients With Lymphoma
37. Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy
38. Can the Student Outperform the Master? A Plan Comparison Between Pinnacle Auto-Planning and Eclipse knowledge-Based RapidPlan Following a Prostate-Bed Plan Competition
39. Clinical implementation of intensity-modulated radiation therapy
40. Intensity-modulated radiation therapy (IMRT): the radiation oncologist’s perspective
41. Independent dose calculations for the CORVUS MLC IMRT
42. Commissioning and quality assurance for Mlc-Based IMRT
43. Leaf sequencing techniques for Mlc-Based IMRT
44. Immobilization devices for intensity-modulated radiation therapy (IMRT)
45. Quality assurance procedures for the peacock system
46. Independent dose calculations for the Peacock system
47. Commissioning of Peacock system for intensity-modulated radiation therapy
48. Dosimetric evaluation of abutted fields using asymmetric collimators for treatment of head and neck
49. Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails
50. Radiation for diffuse large B-cell lymphoma: more questions than answers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.